Yuka Tanaka

Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas

Yuka Tanaka, Shuji Momose, Takayuki Tabayashi et al. · Cancer Science · 2019 · 29 citations · Full text

Medicine, Hematology, Oncology +15

The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders

Michihide Tokuhira, Yuka Tanaka, Yasuyuki Takahashi et al. · Journal of Clinical and Experimental Hematopathology · 2020 · 18 citations · Full text

Medicine, Hematology, Immunology +11

Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma

Takahisa Yamashita, Morihiro Higashi, Shuji Momose et al. · Scientific Reports · 2020 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +15

<scp>CD24</scp> is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma

Morihiro Higashi, Shuji Momose, Natsuko Takayanagi et al. · The Journal of Pathology Clinical Research · 2022 · 14 citations · Full text

Medicine, Immunology, Oncology +17

Endodermal cyst in the cerebellopontine angle with immunohistochemical reactivity for CA19-9.

Kotaro Akaishi, Kazuhiro Hongo, Ito M et al. · PubMed · 2001 · 13 citations

Medicine, Neurological Surgery, Neurosurgery +13